Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2011-02-15 Capital/Financing Update
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
SALPIETRA NOTE II FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the issuance of a promissory note, a material definitive agreement, and related financial terms. It does not contain financial statements or detailed financial performance data, nor is it an earnings release or annual/interim report. It is an announcement of a financing event (issuance of a promissory note) and related agreements. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short (3810 characters), consistent with a current report rather than a full financial report. Confidence is high due to clear identification of the filing type and content.
2011-02-15 English
10-Q 1ST QUARTER 2011
Interim / Quarterly Report Q1 2011
2011-02-14 English
2011 ANNUAL MEETING RESULTS
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filing reporting the results of the company's annual meeting held on February 7, 2011. It details the voting outcomes for board member elections, stock split approval, bylaw amendments, auditor ratification, stock option plan approval, and executive compensation votes. The document is focused on the official results of shareholder votes at the annual meeting. It does not contain financial statements or detailed management discussion, nor is it a presentation or proxy solicitation. The key content is the submission of matters to a vote of security holders, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3614 characters, which is consistent with a voting results announcement rather than a full report or presentation.
2011-02-08 English
SALPIETRA NOTE EXTENSION
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 24, 2011. It reports an extension of a promissory note and the right to convert it into common stock shares. The content focuses on a material definitive agreement related to financing and capital structure changes. The document length is 2692 characters, which is relatively short and contains specific event disclosure rather than comprehensive financial data or analysis. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other categories. Therefore, the appropriate classification is CAP with high confidence.
2011-01-24 English
DEFINITIVE PROXY 2011
Proxy Solicitation & Information Statement
2011-01-20 English
AMENDMENT NO. 1 TO FORM 10-K
Annual Report FY 2010
2011-01-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.